Text Size

Vancomycin Serum Concentrations in Pediatric Oncology Patients Under Intensive Care

This study is currently recruiting participants.
Verified March 2012 by Grupo de Apoio ao Adolescente e a Crianca com Cancer
Sponsor:
Information provided by (Responsible Party):
GLAUCIA TORIBIO FINOTI SEIXAS, Grupo de Apoio ao Adolescente e a Crianca com Cancer
ClinicalTrials.gov Identifier:
NCT01304459
First received: February 24, 2011
Last updated: March 21, 2012
Last verified: March 2012
History of Changes
  Purpose

Observational protocol to analyse routine vancomycin serum levels of patients under intensive care and to obtain percentage of patients that achieve therapeutic values.


Condition
Infection

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Vancomycin Serum Concentrations in Pediatric Oncology Patients Under Intensive Care

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Grupo de Apoio ao Adolescente e a Crianca com Cancer:

Estimated Enrollment: 50
Study Start Date: January 2011
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Pediatric oncology patients on intensive care unit for treatment of infections.

Criteria

Inclusion Criteria:

  • Hospitalized pediatric oncology patients
  • Patients under vancomycin treatment
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01304459

Contacts
Contact: Glaucia T Finoti, MD 55-11-5080-8575 glaucia.finoti@gmail.com

Locations
Brazil
Grupo de Apoio ao Adolescente e à Criança com Câncer Recruiting
Sao Paulo, Brazil, 04023-062
Sponsors and Collaborators
Grupo de Apoio ao Adolescente e a Crianca com Cancer
  More Information

No publications provided

Responsible Party: GLAUCIA TORIBIO FINOTI SEIXAS, MD, Grupo de Apoio ao Adolescente e a Crianca com Cancer
ClinicalTrials.gov Identifier: NCT01304459     History of Changes
Other Study ID Numbers: UTI/IOP 01/11, 1913/10
Study First Received: February 24, 2011
Last Updated: March 21, 2012
Health Authority: Brazil: Ethics Committee

Additional relevant MeSH terms:
Vancomycin
Anti-Bacterial Agents
Anti-Infective Agents
Therapeutic Uses
Pharmacologic Actions

ClinicalTrials.gov processed this record on May 16, 2013